328 related articles for article (PubMed ID: 31312878)
1. Cell-surface molecule-mediated cell-cell interactions in the regulation of ILC2-driven allergic inflammation.
Lei A; Zhou J
Cell Mol Life Sci; 2019 Nov; 76(22):4503-4510. PubMed ID: 31312878
[TBL] [Abstract][Full Text] [Related]
2. Trained innate lymphoid cells in allergic diseases.
Ebihara T; Tatematsu M; Fuchimukai A; Yamada T; Yamagata K; Takasuga S; Yamada T
Allergol Int; 2021 Apr; 70(2):174-180. PubMed ID: 33328130
[TBL] [Abstract][Full Text] [Related]
3. Localization and site-specific cell-cell interactions of group 2 innate lymphoid cells.
Kiniwa T; Moro K
Int Immunol; 2021 Apr; 33(5):251-259. PubMed ID: 33403383
[TBL] [Abstract][Full Text] [Related]
4. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate.
Thio CL; Chi PY; Lai AC; Chang YJ
J Allergy Clin Immunol; 2018 Dec; 142(6):1867-1883.e12. PubMed ID: 29522844
[TBL] [Abstract][Full Text] [Related]
5. Group 2 innate lymphoid cells in the regulation of immune responses.
Roediger B; Weninger W
Adv Immunol; 2015; 125():111-54. PubMed ID: 25591466
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in group 2 innate lymphoid cell-dominant allergic airway inflammation.
Wang C; Xu ZB; Peng YQ; Zhang HY; Yu QN; Guo YB; Tan WP; Liu YL; Meng XC; Fang SB; Chen D; Fu QL
Mol Immunol; 2020 Dec; 128():89-97. PubMed ID: 33096416
[TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
8. C3a is required for ILC2 function in allergic airway inflammation.
Gour N; Smole U; Yong HM; Lewkowich IP; Yao N; Singh A; Gabrielson E; Wills-Karp M; Lajoie S
Mucosal Immunol; 2018 Nov; 11(6):1653-1662. PubMed ID: 30104625
[TBL] [Abstract][Full Text] [Related]
9. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
Symowski C; Voehringer D
Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
[TBL] [Abstract][Full Text] [Related]
10. IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation.
Roediger B; Kyle R; Tay SS; Mitchell AJ; Bolton HA; Guy TV; Tan SY; Forbes-Blom E; Tong PL; Köller Y; Shklovskaya E; Iwashima M; McCoy KD; Le Gros G; Fazekas de St Groth B; Weninger W
J Allergy Clin Immunol; 2015 Dec; 136(6):1653-1663.e7. PubMed ID: 26025126
[TBL] [Abstract][Full Text] [Related]
11. Adenosine restrains ILC2-driven allergic airway inflammation via A2A receptor.
Xiao Q; Han X; Liu G; Zhou D; Zhang L; He J; Xu H; Zhou P; Yang Q; Chen J; Zhou J; Jiang G; Yao Z
Mucosal Immunol; 2022 Feb; 15(2):338-350. PubMed ID: 34921233
[TBL] [Abstract][Full Text] [Related]
12. The Prostaglandin D
Oyesola OO; Duque C; Huang LC; Larson EM; Früh SP; Webb LM; Peng SA; Tait Wojno ED
J Immunol; 2020 Feb; 204(4):1001-1011. PubMed ID: 31900341
[TBL] [Abstract][Full Text] [Related]
13. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation.
Wallrapp A; Riesenfeld SJ; Burkett PR; Abdulnour RE; Nyman J; Dionne D; Hofree M; Cuoco MS; Rodman C; Farouq D; Haas BJ; Tickle TL; Trombetta JJ; Baral P; Klose CSN; Mahlakõiv T; Artis D; Rozenblatt-Rosen O; Chiu IM; Levy BD; Kowalczyk MS; Regev A; Kuchroo VK
Nature; 2017 Sep; 549(7672):351-356. PubMed ID: 28902842
[TBL] [Abstract][Full Text] [Related]
14. A mitochondrial STAT3-methionine metabolism axis promotes ILC2-driven allergic lung inflammation.
Fu L; Zhao J; Huang J; Li N; Dong X; He Y; Wang W; Wang Y; Qiu J; Guo X
J Allergy Clin Immunol; 2022 Jun; 149(6):2091-2104. PubMed ID: 34974065
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology.
Sunaga S; Tsunoda J; Teratani T; Mikami Y; Kanai T
Front Immunol; 2022; 13():867351. PubMed ID: 35707544
[TBL] [Abstract][Full Text] [Related]
16. Activation of group 2 innate lymphoid cells exacerbates and confers corticosteroid resistance to mouse nasal type 2 inflammation.
Morikawa T; Fukuoka A; Matsushita K; Yasuda K; Iwasaki N; Akasaki S; Fujieda S; Yoshimoto T
Int Immunol; 2017 May; 29(5):221-233. PubMed ID: 28541554
[TBL] [Abstract][Full Text] [Related]
17. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation.
Klose CSN; Mahlakõiv T; Moeller JB; Rankin LC; Flamar AL; Kabata H; Monticelli LA; Moriyama S; Putzel GG; Rakhilin N; Shen X; Kostenis E; König GM; Senda T; Carpenter D; Farber DL; Artis D
Nature; 2017 Sep; 549(7671):282-286. PubMed ID: 28869965
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-induced endogenous production of prostaglandin D
Maric J; Ravindran A; Mazzurana L; Van Acker A; Rao A; Kokkinou E; Ekoff M; Thomas D; Fauland A; Nilsson G; Wheelock CE; Dahlén SE; Ferreirós N; Geisslinger G; Friberg D; Heinemann A; Konya V; Mjösberg J
J Allergy Clin Immunol; 2019 Jun; 143(6):2202-2214.e5. PubMed ID: 30578872
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E
Maric J; Ravindran A; Mazzurana L; Björklund ÅK; Van Acker A; Rao A; Friberg D; Dahlén SE; Heinemann A; Konya V; Mjösberg J
J Allergy Clin Immunol; 2018 May; 141(5):1761-1773.e6. PubMed ID: 29217133
[TBL] [Abstract][Full Text] [Related]
20. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells.
Klein Wolterink RG; Serafini N; van Nimwegen M; Vosshenrich CA; de Bruijn MJ; Fonseca Pereira D; Veiga Fernandes H; Hendriks RW; Di Santo JP
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10240-5. PubMed ID: 23733962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
